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Abstract Activation of the Gs G protein–coupled recep-
tor Rs1 in osteoblasts increases bone mineral density by
5- to 15-fold in mice and recapitulates histologic aspects of
ﬁbrous dysplasia of the bone. However, the effects of
constitutive Gs signaling on bone tissue quality are not
known. The goal of this study was to determine bone tissue
quality in mice resulting from osteoblast-speciﬁc consti-
tutive Gs activation, by the complementary techniques of
FTIR spectroscopy and synchrotron radiation micro-com-
puted tomography (SRlCT). Col1(2.3)-tTA/TetO-Rs1
double transgenic (DT) mice, which showed osteoblast-
speciﬁc constitutive Gs signaling activity by the Rs1
receptor, were created. Femora and calvariae of DT and
wild-type (WT) mice (6 and 15 weeks old) were analyzed
by FTIR spectroscopy. WT and DT femora (3 and 9 weeks
old) were imaged by SRlCT. Mineral-to-matrix ratio was
25% lower (P = 0.010), carbonate-to-phosphate ratio was
20% higher (P = 0.025), crystallinity was 4% lower
(P = 0.004), and cross-link ratio was 11% lower (P =
0.025) in 6-week DT bone. Differences persisted in
15-week animals. Quantitative SRlCT analysis revealed
substantial differences in mean values and heterogeneity of
tissue mineral density (TMD). TMD values were 1,156 ±
100 and 711 ± 251 mg/cm
3 (mean ± SD) in WT and DT
femoral diaphyses, respectively, at 3 weeks. Similar dif-
ferences were found in 9-week animals. These results
demonstrate that continuous Gs activation in murine oste-
oblasts leads to deposition of immature bone tissue with
reduced mineralization. Our ﬁndings suggest that bone
tissue quality may be an important contributor to increased
fracture risk in ﬁbrous dysplasia patients.
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Fibrous dysplasia of bone
Osteoblast G protein–coupled receptors (GPCRs) are fun-
damental regulators of skeletal maintenance and repair.
Activation of osteoblast Gs-GPCR signaling increases bone
mass, as in pathological conditions such as ﬁbrous dys-
plasia of the bone and McCune-Albright syndrome [1, 2].
However, the affected bone is associated with increased
fragility. In contrast, intermittent activation of the para-
thyroid hormone receptor (PTH1R) by recombinant para-
thyroid hormone (teriparatide) [3] increases bone
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Manipulation of skeletal GPCR signaling, therefore, is a
potentially potent technique for regulating disease pro-
cesses and enhancing repair of bone tissue [4].
The skeletal effects of Gs-GPCR signaling on bone
formation were investigated with the Col1(2.3)-tTA/TetO-
Rs1 mouse model of ﬁbrous dysplasia of the bone. This
model uses a synthetic biology approach [4] to activate the
Gs signaling pathway in maturing mouse osteoblasts by the
constitutive Gs activity of the Rs1 engineered receptor
activated solely by a synthetic ligand (RASSL) [5, 6].
RASSLs are engineered receptors that no longer respond to
endogenous hormones but are activated by synthetic small-
molecule drugs. They have been useful for studying the
roles of G-protein signaling in a variety of in vivo systems
[7–10]. In the Col1(2.3)-tTA/TetO-Rs1 mouse model, Rs1
expression was sufﬁcient to induce a dramatic increase in
skeletal bone mass and trabecular bone formation [6]. In
addition, cortical bone was lost, the normal bone marrow
canal was obliterated, and the normal bone marrow cellular
components were replaced by a large number of small cells
that histologically resemble young osteoblasts. These fea-
tures show strong similarity to the bony lesions in patients
with ﬁbrous dysplasia of the bone, a disease that also
results from activation of the Gs signaling pathway [1, 2].
While elevated osteoblast Gs signaling has signiﬁcant
effects on bone mass and structure, the quality of the
resulting bone tissue has not been thoroughly investigated.
Characteristics of bone tissue quality, including mineral
content and composition, crystal size and perfection, and
collagen matrix stability, are critical to the mechanical
competence [11–14] and remodeling characteristics [15,
16] of bone. Therefore, evaluation of tissue quality metrics
is crucial for understanding the anabolic effect of consti-
tutive Gs signaling on bone and for developing effective
treatments for skeletal pathology.
We applied two complementary strategies for assessing
bone quality in mice with osteoblast-speciﬁc constitutive
Gs signaling activity: Fourier transform infrared (FTIR)
spectroscopy, to investigate tissue quality at the molecular
level, and synchrotron radiation micro-computed tomog-
raphy (SRlCT), to provide accurate quantiﬁcation of bone
tissue mineral density (TMD) at high spatial resolution.
FTIR spectroscopy provides a method for examining
tissuequalityandcompositionbymeasuringmolecularbond
vibration frequencies [17, 18]. FTIR spectra of calciﬁed
tissues typically provide information on the structure and
environment of the carbonate and phosphate groups of the
mineral phase and the amide groups of the organic matrix.
Metrics of bone quality can be calculated from these data.
Speciﬁcally, these parameters include mineral-to-matrix
ratio (correlated to ash density [19, 20]), carbonate-to-
phosphateratio(reﬂectingthelevelofcarbonatesubstitution
into the apatite lattice [15, 21]), crystallinity (related to
crystal size and perfection as determined by X-ray diffrac-
tion [22, 23]), and collagen cross-link ratio (the ratio of
nonreducible to reducible cross-links, indicating collagen
maturity and stability [24]). These FTIR parameters provide
information on the structure and mineralization of the inor-
ganic and organic components of bone.
SRlCT enables accurate TMD quantiﬁcation at high
spatial resolution. In this technique, a high photon ﬂux
monochromatic X-ray beam extracted from a synchrotron
beam replaces the standard polychromatic X-ray beam
used in conventional lCT devices. The use of a single
X-ray beam energy eliminates beam-hardening artifacts,
the high photon ﬂux produces a high signal-to-noise ratio
and high spatial resolution, and the use of a nearly parallel
beam enables exact 3D tomographic reconstruction. Due to
these factors, TMD quantiﬁcation by SRlCT is more
accurate than that by conventional lCT. SRlCT TMD
assessment has been veriﬁed against gravimetric methods
(ashing) [25] and 2D microradiography [26] and is cur-
rently considered the gold standard for high-resolution 3D
TMD evaluation.
In this study, we used FTIR spectroscopy and SRlCT to
evaluate measures of bone tissue mineralization, compo-
sition, and maturity in mice with osteoblast-speciﬁc con-
stitutive Gs signaling activity. Our results show that the
bone formed by activated Gs signaling is more immature
and has lower mineralization than that of wild-type (WT)
controls. These ﬁndings suggest that reduced bone quality
contributes to increased bone fragility in ﬁbrous dysplasia
patients. In addition, our results illustrate that metrics of
bone tissue quality are important in investigating signaling
mechanisms.
Materials and Methods
Mouse Model
All transgenic mouse studies were approved by and per-
formed in accordance with the Institutional Animal Care
and Use Committee and the Laboratory Animal Research
Center at the University of California, San Francisco.
ColI(2.3)-tTA/TetO-Rs1 double transgenic (DT) mice were
generated by heterozygote crosses of mice carrying the
TetO-Rs1 transgene [6] with mice carrying the ColI(2.3)-
tTA transgene [27], as described [6]. Transgene expression
was activated by maintaining the mice on regular mouse
chow without doxycycline (LabDiet 5053; PMI Nutrition,
St. Louis, MO). These transgenic mice display osteoblast-
speciﬁc constitutive Gs signaling activity through the Rs1
receptor. Previous qPCR assays on whole femora of
6-week-old adult mice showed that Rs1 expression was
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All studies compared DT mice to WT littermate controls.
FTIR Spectroscopy
Femora and calvariae of DT and WT mice were analyzed
by FTIR spectroscopy. Mice of two ages were evaluated:
6 weeks (n = 6 WT, 6 DT) and 15 weeks (n = 6 WT, 6
DT). Bones were excised, stripped of soft tissue, and ﬁxed
in 70% ethanol. The desired region of each specimen was
isolated and desiccated through an ethanol series, followed
by exposure in a desiccant chamber. The sampled regions
were the mid-diaphysis of the left femur and the left pos-
terior quadrant (parietal bone) of the calvaria (Fig. 1). For
each sample, a 2-mg (approximately 2 mm long) bone
segment was isolated and a homogenized powder mixture
was created of 1% bone by weight in potassium bromide
(KBr; Thermo Electron, Waltham, MA). The powder
mixture was compressed using a manual die to create a
pellet for FTIR spectroscopy.
Spectroscopy was performed on a benchtop interfer-
ometer system (Nexus 870, Thermo Electron). Spectra
were acquired using 256 scans at a spectral resolution of
4c m
-1. A background scan was recorded immediately
after each sample scan to facilitate background correction.
After acquisition, the spectra were transferred to chemical
imaging software (Isys; Spectral Dimensions, Olney, MD)
for analysis. Spectra were baseline-adjusted and the inte-
grated areas of the amide I (1,595–1,720 cm
-1), m1m3
phosphate (PO4
3-, 895–1,215 cm
-1), and v2 carbonate
(CO3
2-, 840–890 cm
-1) bands were calculated. Mineral-
to-matrix (PO4
3-/amide I), carbonate-to-phosphate
(CO3
2-/PO4
3-), and carbonate-to-matrix (CO3
2-/amide I)
ratios were calculated from integrated areas of the
respective peaks. Additionally, peak heights were mea-
sured at speciﬁc wave numbers: 1,020, 1,030, 1,660, and
1,690 cm
-1. From these, a series of absorbance ratios were
calculated to determine additional spectroscopic parame-
ters. The ratio of 1,030 to 1,020 cm
-1 represents the ratio
of stoichiometric apatite to nonstoichiometric apatite, a
measure of crystallinity. Finally, the ratio of 1,660 to
1,690 cm
-1 represents the proportion of nonreducible to
reducible cross-links in the collagen, indicative of collagen
maturity.
FTIR Spectroscopy—Repeatability
Left femora from each of three 15-week-old WT mice were
used to assess repeatability of FTIR measures. From each
femur, a mid-diaphyseal section was isolated and processed
into a homogeneous powder mixture of 1% bone by weight
in KBr as described above. Three pellets were created from
each batch of the homogenized mixture, and the remaining
powder was stored in the desiccator to prevent hydration
Fig. 1 Calvariae and femora of
representative wild-type (WT)
and double transgenic (DT)
mice harvested at 6 and
15 weeks of age for FTIR
analysis. DT mice exhibited
increased femoral girth and
calvarial thickness at 6 weeks,
becoming more dramatic at
15 weeks. Scale bar 5 mm for
each image
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123between each pellet preparation. Spectroscopy and analysis
of the three pellets from each bone were performed con-
secutively on a single day, following the methods detailed
in the previous section.
Synchrotron lCT Imaging
One representative femur from 3- and 9-week-old WT and
DT mice was imaged using SRlCT. Femora were dis-
sected, stripped of soft tissue, ﬁxed in 10% neutral buffered
formalin for 24 h, and stored in 70% ethanol before
imaging. The distal surface of the femoral condyles was
mounted onto a block for imaging with a wax-based
adhesive. Synchrotron imaging was performed at the
European Synchrotron Radiation Facility (Grenoble,
France). Beamline ID19 of this facility is equipped with a
lCT acquisition system capable of producing high-reso-
lution 3D images with high contrast and signal-to-noise
ratio [28]. Images were acquired using a single energy
(21 keV) chosen to provide suitable contrast. The trans-
mitted monochromatic X-ray beam was recorded using a
scintillator coupled to a 2D 1,024 9 1,024 charge coupled
device (CCD) camera. The optical system was arranged to
produce a pixel size of 5 lm. Dark current and reference
images without the specimen were taken during acquisition
for ﬂat ﬁeld correction. Three-dimensional images were
reconstructed by means of a 3D ﬁltered back-projection
algorithm from 900 projections. A local thresholding
scheme [29] was employed to segment the bone from
background (Fig. 2). This local thresholding scheme was
necessitated by the variations in voxel intensity observed in
the synchrotron images; global thresholds failed to capture
the entire mineralized region, particularly in DT bone, and
therefore underestimated TMD variation and miscalculated
mean TMD. After segmentation, average linear attenuation
was calculated and directly converted to TMD with a
theoretical relationship modeling linear attenuation coefﬁ-
cient as a function of hydroxyapatite concentration.
DXA Analysis
Whole-body DXA scans of WT and DT mice were per-
formed for animals aged 3 weeks (n = 10 WT, 14 DT),
6 weeks (n = 10 WT, 10 DT), 9 weeks (n = 8W T ,1 4
DT), and 15 weeks (n = 7 WT, 7 DT) to assess phenotype
progression. Whole-body DXA scans were performed
under anesthesia with 1% isoﬂurane in a Lunar PIXImus2
(GE Lunar, Waukesha, WI), as described previously [6].
Histology
Femora of 6-week-old DT and WT mice collected for
histology were ﬁxed in 10% neutral buffered formalin for
24 h. Undecalciﬁed femora were embedded in polymethyl
methacrylate [6], and 4-l sections were cut on a hard-tissue
microtome. Decalciﬁed bones were processed in 10%
EDTA, embedded in parafﬁn, sectioned, and stained with
hematoxylin and eosin (H&E) by the Gladstone Institutes
Histology Core (San Francisco, CA). Mid-diaphyseal
regions of interest were visualized to grossly assess phe-
notypic changes.
Statistics
Wilcoxon signed-rank tests revealed no signiﬁcant differ-
ences in FTIR spectroscopic parameters between the two
anatomic sites (femur, calvaria); therefore, values were
averaged to produce a single result per animal. Results
obtained from WT and DT mouse specimens were com-
pared using t-tests or Wilcoxon rank sums tests as appro-
priate. Repeatability of FTIR measures was determined by
calculating the coefﬁcient of variation (CV) for each
Fig. 2 Mid-diaphyseal femoral cross section of a 3-week-old double
transgenic mouse. Gray-scale data (a) were processed using a local
thresholding algorithm that incorporates edge detection (b, center
panel shows result of edge detection), allowing accurate segmentation
(b, right panel shows result of segmentation) despite the existence of
ﬁne structures and dramatic spatial variation in attenuation. A
rendering of the resulting 3D segmented data set is shown (c)
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femora used in the repeatability study.
Results
FTIR Spectroscopy
FTIR spectroscopy was performed to assess bone quality in
young (6 weeks) and mature (15 weeks) WT and DT mice.
No differences in FTIR spectroscopic parameters were
detected between the two anatomic sites we tested (femora
and calvaria) for either WT or DT animals, despite the
different bone-formation processes (endochondral vs.
intramembranous) represented by the two sites.
Signiﬁcant differences in FTIR spectroscopic measures
of bone composition were found between 6-week-old WT
and DT mice (Table 1, Fig. 3). Mineral-to-matrix ratio was
25% lower in DT bone (P = 0.010), carbonate-to-phos-
phate ratio was 20% higher (P = 0.025), crystallinity was
4% lower (P = 0.004), and cross-link ratio was 11% lower
(P = 0.025). These differences persisted in 15-week-old
animals. No differences were found between WT and DT
mice in carbonate-to-matrix ratio (P = 0.084 at 6 weeks,
P = 0.107 at 15 weeks). Differences associated with ani-
mal age were detected only in WT mice. WT carbonate-to-
phosphate ratio increased 17% from 6 to 15 weeks
(P = 0.017), carbonate-to-matrix ratio increased 49% (P =
0.007), and cross-link ratio decreased 8% (P = 0.037).
Change in carbonate-to-matrix ratio with age approached
signiﬁcance in DT mice (25% increase, P = 0.050). These
results indicate that bone tissue in DT mice is more
immature than that in WT mice. In addition, while WT
tissue matured as the mice aged, DT mice retained their
immature tissue composition.
FTIR Spectroscopy—Repeatability
Mean CV values were calculated to assess repeatability of
the FTIR measurements. Mean CV for FTIR measures
ranged from 0.3% to 3.9%, with crystallinity displaying the
lowest variation and carbonate-to-phosphate ratio display-
ing the highest variation for the samples tested (Table 2).
SRlCT Imaging
SRlCT data were evaluated to assess bone microstructure
and TMD. Synchrotron imaging revealed dramatic differ-
ences in structure between WT and DT femora (Fig. 4).
The 3-week-old DT femur had no distinct marrow cavity or
cortical shell but, rather, a disorganized trabecular pattern
throughout the cross section. This structural abnormality
persisted in the 9-week-old DT femur. Quantitative anal-
ysis of the synchrotron data revealed differences in TMD
mean and variance values. TMD values were 1,156 ± 100
and 711 ± 251 mg/cm
3 (mean ± SD) in WT and DT
femur diaphyses, respectively, at 3 weeks and 1,205 ± 72
and 813 ± 133 mg/cm
3 in WT and DT mice, respectively,
at 9 weeks. These results show that tissue composition and
organization are altered in DT mice.
DXA Analysis
Whole-body BMD values were measured for DT and WT
mice at 3, 6, 9, and 15 weeks of age to evaluate skeletal
growthovertherangeofagesassessedviaFTIRandSRlCT
(Fig. 5). At 3 weeks of age DT mice had BMD values sta-
tistically indistinguishable from those of WT mice. BMD of
DT mice was 103% that of their WT littermates by 6 weeks
of age and 165% by 9 weeks (P\0.003). BMD of DT mice
remained constant through 15 weeks, with no statistically
signiﬁcant change detectable relative to the 9-week mea-
surement. These results indicate that the accumulation of
bone mineral in DT mice persists through sexual maturity,
then plateaus in mature mice ([8 weeks).
Histology
Undecalciﬁed sections were processed to visualize cortical
and trabecular structure. Decalciﬁed sections were stained
Table 1 FTIR analysis results for wild-type (WT) and double transgenic (DT) mice
6-week animals 15-week animals
WT (n = 6) DT (n = 6) P WT (n = 6) DT (n = 6) P
Phosphate:amide I 5.14 ± 0.68 3.85 ± 0.66 0.010 5.77 ± 0.83 4.10 ± 0.60 0.007
Carbonate:amide I 0.059 ± 0.007* 0.053 ± 0.006 0.084 0.088 ± 0.03* 0.066 ± 0.011 0.107
Carbonate:phosphate 0.012 ± 0.001* 0.014 ± 0.002 0.025 0.014 ± 0.001* 0.016 ± 0.001 0.006
Crystallinity 1,030/1,020 1.06 ± 0.01 1.02 ± 0.01 0.004 1.05 ± 0.01 1.02 ± 0.01 0.014
Cross-link ratio 1,660/1,690 1.73 ± 0.08* 1.54 ± 0.15 0.025 1.59 ± 0.11* 1.41 ± 0.06 0.010
Data for calvariae and femora were not different (P[0.05); one mean value per animal was used for this analysis
* P\0.05 by Wilcoxon rank sums test; all other 6- vs. 15-week comparisons, nonsigniﬁcant
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123with H&E to reveal cellular, matrix, and marrow compo-
nents. A disordered mineralization pattern with effacement
of the cortical compartment and elimination of the med-
ullary canal was seen in these images (Fig. 6), in agree-
ment with our previous ﬁnding that Rs1-induced basal Gs
signaling in osteoblasts of DT mice increased trabecular
bone and decreased cortical bone in lesions, reminiscent of
ﬁbrous dysplasia of the bone [6].
Discussion
Our results show that continuous Gs activation in mouse
osteoblasts leads to deposition of large quantities of
immature trabecular bone with reduced mineralization.
FTIR spectroscopy revealed a 25–29% deﬁcit in mineral-
to-matrix ratio in the bones of mice expressing Rs1, and
synchrotron imaging showed a reduced mean TMD. These
ﬁndings are consistent with low levels of bone minerali-
zation. Measures of mineral composition, mineral maturity,
and collagen maturity also indicate signiﬁcant abnormali-
ties in bone formation induced by Gs activation in maturing
osteoblasts. These alterations in tissue quality accompany
dramatic structural changes, including greatly increased
bone mass, increased heterogeneity of mineralization, dis-
organization of trabecular morphology, effacement of the
cortical shell, and elimination of the medullary canal.
Our model is particularly relevant for GPCR diseases
found in humans, including primary hyperparathyroidism
and ﬁbrous dysplasia of the bone such as that occurring in
McCune-Albright syndrome. Patients with primary hyper-
parathyroidism present with marked cortical thinning and
decreased cortical BMD [30, 31], possibly related to
increased cortical porosity [32–34]. The elimination of the
cortical compartment in DT mice is an extreme version of
the cortical loss seen in primary hyperparathyroidism.
However, the massive increase in trabecular volume
observed in DT mice is not generally seen in patients with
hyperparathyroidism. Bone from McCune-Albright syn-
drome patients shows a ﬁbrous inﬁltrate, signiﬁcant
increases in trabecular bone formation, ablation of the
marrow cavity, and an increased propensity to deformation
and fracture [35]. In addition, these patients accumulate
unmineralized osteoid with a nonlamellar structure as well
as mineralized tissue with markedly reduced mineral con-
tent [1, 36]. The mineralization abnormalities found in our
mouse model of ﬁbrous dysplasia may reﬂect those in
patients with ﬁbrous dysplasia of the bone.
FTIR spectroscopic measures provide bone tissue char-
acterization at the molecular level and, importantly, are
correlated with mechanical integrity and remodeling
properties of the tissue. Mineral-to-matrix ratio increases as
Fig. 3 FTIR spectroscopic results for 6- and 15-week wild-type (WT)
and double transgenic (DT) mice. Signiﬁcant variations from WT
controls were evident in FTIR parameters describing mineral content,
crystallinity, and collagen cross-links in DT bone at 6 weeks. These
differences persisted in 15-week-old animals. As measurements for
calvariaeandfemorawerenotdifferent(P[0.05),onemeanvalueper
animal was used for this analysis. Bars indicate signiﬁcant differences
between WT and DT animals (all P\0.03). Asterisks indicate
signiﬁcant differences between 6- and 15-week animals (all P\0.05)
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therefore, is positively associated with tissue age [12, 37].
Studies of human tissue and animal models demonstrated
positive correlations between mineral-to-matrix ratio and
tissue stiffness and hardness [12, 38, 39]. Mineral-to-
matrix ratio explains 50–60% of the variation in both tissue
modulus and hardness [37, 40]. In our study, decreased
mineral-to-matrix ratio in DT bone suggests the presence
of immature bone with reduced resistance to deformation.
Since FTIR crystallinity values are positively associated
with tissue age, tissue yield strength, and stiffness [12, 14,
37], the decreased crystallinity we observed in DT bone
substantiates the presence of immature tissue with reduced
mechanical properties. We previously showed that DT
animals have markedly elevated bone-turnover markers;
display irregular, punctate bone formation by von Kossa
staining and double ﬂuorescent labeling; and have
increased numbers of TRAP-positive osteoclasts [6]. These
characteristics support the conclusion that DT bone lesions
contain regions with extremely high rates of bone forma-
tion and turnover, consistent with our ﬁndings of accu-
mulated immature tissue.
Increased carbonate substitution has been associated
with increased tissue age [12, 15, 41, 42], increased tissue
Table 2 Repeatability of FTIR spectroscopic parameters
Phosphate:amide I Carbonate:amide I Carbonate:phosphate Crystallinity 1,030/1,020 Cross-link ratio 1,660/1,690
Mean CV 1.15 3.46 3.86 0.32 1.72
Fig. 4 Full bone renderings and
detailed sections from the mid-
diaphysis of femora from
3-week-old wild-type (WT) and
double transgenic (DT) mice
(upper panel). Mid-diaphyseal
cross section of a 9-week-old
DT mouse (lower panel).
SRlCT images illustrate a
disordered mineralization
pattern, lack of dense cortical
tissue, and elimination of
central marrow cavity.
Histograms compiled from
synchrotron data of 3-week-old
samples reveal decreased mean
and increased variance in tissue
mineral density in DT bone
Fig. 5 BMD measured in age-matched wild-type (WT) and double
transgenic (DT) littermates. Whole-body BMD values of DT mice
were 103%, 165%, and 145% higher than those of WT littermate
controls at 6, 9, and 15 weeks of age, respectively (*P\0.0003 by
t-test of DT vs. WT)
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123indentation modulus and hardness [40], and—by a mech-
anism of reduced ductility—increased incidence of fracture
[43] and inferior mechanical properties at the whole-bone
level [20]. Carbonate substitution in the hydroxyapatite
lattice leads to a change in lattice dimensions and increased
disorder of the crystalline structure [44]. Further, mineral
solubility is affected by carbonate content and increased
carbonate content is thought to enhance bone resorption
[45]. Carbonate-to-phosphate ratio was signiﬁcantly ele-
vated in DT bone, indicating an alteration in crystal syn-
thesis and perhaps playing a role in the high turnover
observed in DT animals [6].
Collagen matrix biochemistry is also related to tissue
age, mineralization, and mechanics. Intermolecular cross-
linking provides the matrix tensile strength and inﬂuences
whole-bone strength [46–49]. Cross-link formation also
alters the rate of mineralization and microdamage accu-
mulation [50], thereby providing a second mechanism for
regulating the mechanical properties of bone [51]. The
ratio of mature to immature, reducible cross-links—quan-
tiﬁed as cross-link ratio—increases with tissue maturity
[52, 53] and correlates positively with indentation modulus
[12]. In DT bone, low cross-link ratio indicates immature
tissue with reduced stiffness.
FTIR analyses showed that DT bone does not exhibit
maturation between 6 and 15 weeks. In contrast, specimens
from 6- and 15-week-old WT mice showed signiﬁ-
cant differences in carbonate-to-matrix and carbonate-
to-phosphate ratios, indicative of increasingly mature tis-
sue. Cross-link ratio decreased in WT animals, in contrast
to the established association between cross-link ratio and
matrix maturation.
SRlCT imaging was used to quantify mean TMD and
distribution of TMD values, measures complementary to
thosedeterminedthroughFTIRanalysis.Consistentwiththe
deﬁcit in mineral-to-matrix ratio identiﬁed by FTIR, DT
bone had mean TMD values 39% and 33% lower than WT
bone at 3 and 9 weeks, respectively. SRlCT also revealed
increased heterogeneity in mineral content in DT mice as
reﬂected by the large standard deviation of TMD in DT
bones at 3 and 9 weeks (151% and 88% higher, respec-
tively). The alteration in distribution of mineralization val-
ues might signiﬁcantly affect the overall material properties
of DT bone; heterogeneous regions of tissue mineralization
may hinder crack propagation and toughen tissue. It is
intriguing to consider that the increased variation in TMD
may represent a compensatory mechanism by which DT
mice counteract the deﬁcit in tissue mineralization.
Increased tissue volume in DT animals may represent an
additional adaptive response to the formation of hypomin-
eralized tissue and loss of cortical structure. These changes
maypartiallyorfullycompensateforanylossofwhole-bone
strength or stiffness. No spontaneous fractures have been
identiﬁedinDTanimals,perhapssupportingthishypothesis.
The presence of immature bone in our mouse model of
ﬁbrous dysplasia suggests that strategies for modulating
Fig. 6 Diaphyseal sections of
representative 6-week-old wild-
type (a, c) and double
transgenic (b, d) femora
visualized by microscopy.
Undecalciﬁed sections (a, b)
and decalciﬁed sections with
H&E staining (c, d) demonstrate
a disordered mineralization
pattern with effacement of a
distinct cortical compartment
and elimination of the marrow
canal in the double transgenic
femur. Scale bars 1m m
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123bone formation, such as antiresorptive medications, may
have therapeutic value for these patients. Since the ﬁbrous
dysplastic bone lesions appear to be reversible by inhibit-
ing Gs signaling [54], the immature bone formation seen in
our DT mice might also be reversed. This would be an
important metric as potential therapies for ﬁbrous dysplasia
are developed.
Despite identifying signiﬁcant effects of Rs1 signaling
on bone mineralization, our study has several limitations.
First, we were unable to perform direct measurement of
mechanical competence in DT mice. Mechanical testing is
challenging in DT specimens due to morphological
abnormalities and heterogeneous mineralization. However,
the compositional measures derived from FTIR and
SRlCT data are highly associated with mechanical prop-
erties of bone tissue and give us insight into the mecha-
nisms of increased fragility in ﬁbrous dysplastic bone.
Second, the ages of animals characterized by FTIR and
SRlCT were different; this should be taken into consid-
eration when making direct comparisons between analysis
results. However, for each analysis technique, the younger
animals (3 and 6 weeks old) were in the rapid skeletal
growth phase, while the older animals (9 and 15 weeks old)
had reached a plateau of bone accumulation. This is sup-
ported by BMD measurements and consistent with the
observed sexual maturity window of 7–8 weeks in both
WT and DT mice. Finally, our ﬁndings are based on
samples from a relatively small number of animals. The
signiﬁcant abnormalities in tissue quality and skeletal
structure we observed in our TD mice were surprisingly
conserved between the two different anatomic sites sam-
pled (femora and parietal bones of calvariae). This ﬁnding
allowed us to compile results from the two skeletal sites
and perform a conservative statistical analysis. Despite
these limitations, we believe that our results provide new
insight into the roles of Gs signaling in regulating the
matrix formation process.
In conclusion, our results illustrate that activation of the
Gs signaling pathway in maturing osteoblasts leads to a
signiﬁcant degradation of bone tissue quality in a mouse
model of ﬁbrous dysplasia. The striking inﬂuence of the
ﬁbrous dysplasia model on tissue quality metrics reinforces
the paradigm that tissue quality, and not just quantity and
structure, must be considered in the evaluation of any
disease processes or potential therapies.
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